CWA
PLXP

Capital Wealth Alliance’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Capital Wealth Alliance’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,000
Closed -$12K – 382
2019
Q4 		$12K Buy
+2,000
New +$9.4K 0.01% 196

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
HWA
Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Wealth Alliance's PLXP Position: Q1 2020 in Review

Capital Wealth Alliance sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2020, closing a stake of 2,000 shares — an estimated $12K sold.

Capital Wealth Alliance first reported a position in PLXP in Q4 2019 and held it in 1 quarter. The position peaked at $12K in Q4 2019. 18 funds tracked by Wall St. Rank hold PLXP as of Q1 2020.

  • Capital Wealth Alliance reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Capital Wealth Alliance sold 2,000 PLx Pharma Inc. Common Stock shares in Q1 2020, an estimated $12K.
  • Capital Wealth Alliance first reported a position in PLx Pharma Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Capital Wealth Alliance's PLx Pharma Inc. Common Stock position peaked at $12K in Q4 2019.
  • 18 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2020.

Based on Capital Wealth Alliance's 13F filing for Q1 2020, filed 28 Apr 2020.